Stock Information
Gilead Sciences Inc (GILD)
Ticker Symbol: GILD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $160,130.83 mil
Piotroski score: 6
PE Ratio: 16.535
EPS (TTM): 7.3515
Revenue (TTM): $23.71 M
Dividend Yield: 2.650290885585%
ROE: 42.21%
Latest News
-
Dividend Champion, Contender, And Challenger Highlights: Week Of June 21
Thu, Jun 18, 2026 8:20 PM
-
VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026
Thu, Jun 18, 2026 2:34 PM
-
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
Thu, Jun 18, 2026 1:00 PM
-
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q1 Earnings?
Thu, Jun 18, 2026 11:09 AM
-
Abivax: Safety Signals Loom Ahead Of The NDA Submission
Thu, Jun 18, 2026 6:53 AM
-
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
Wed, Jun 17, 2026 6:01 PM
-
Gilead Sciences (GILD) Donates Remdesivir to Uganda
Wed, Jun 17, 2026 5:34 PM
-
1 Cash-Producing Stock Worth Investigating and 2 We Brush Off
Wed, Jun 17, 2026 10:28 AM
-
The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK
Wed, Jun 17, 2026 7:41 AM
-
FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV Prevention
Tue, Jun 16, 2026 6:17 PM
Key Financials
Financial data not available
